Correlation Between Orexo AB and Swedish Orphan

Can any of the company-specific risk be diversified away by investing in both Orexo AB and Swedish Orphan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orexo AB and Swedish Orphan into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orexo AB and Swedish Orphan Biovitrum, you can compare the effects of market volatilities on Orexo AB and Swedish Orphan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orexo AB with a short position of Swedish Orphan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orexo AB and Swedish Orphan.

Diversification Opportunities for Orexo AB and Swedish Orphan

-0.46

Correlation Coefficient

Orexo AB  Swedish Orphan

Very good diversification

The 3 months correlation between Orexo and Swedish is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Orexo AB and Swedish Orphan Biovitrum in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swedish Orphan Biovitrum and Orexo AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orexo AB are associated (or correlated) with Swedish Orphan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swedish Orphan Biovitrum has no effect on the direction of Orexo AB i.e., Orexo AB and Swedish Orphan go up and down completely randomly.

Pair Corralation between Orexo AB and Swedish Orphan

Assuming the 90 days trading horizon Orexo AB is expected to generate 1.85 times more return on investment than Swedish Orphan. However, Orexo AB is 1.85 times more volatile than Swedish Orphan Biovitrum. It trades about 0.09 of its potential returns per unit of risk. Swedish Orphan Biovitrum is currently generating about -0.05 per unit of risk. If you would invest  1,908  in Orexo AB on April 24, 2025 and sell it today you would earn a total of  112.00  from holding Orexo AB or generate 5.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.65%
Values	Daily Returns

Orexo AB  vs.  Swedish Orphan Biovitrum

Orexo AB

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orexo AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Orexo AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Swedish Orphan Biovitrum

Risk-Adjusted Performance

Very Weak

Over the last 90 days Swedish Orphan Biovitrum has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Swedish Orphan is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Orexo AB and Swedish Orphan

The main advantage of trading using opposite Orexo AB and Swedish Orphan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orexo AB position performs unexpectedly, Swedish Orphan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swedish Orphan will offset losses from the drop in Swedish Orphan's long position.

The idea behind Orexo AB and Swedish Orphan Biovitrum pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..